retatrutide approval status 2025 FDA Status: July 2026 Update Retatrutide Phase 3 Updates: Significant

However, when analyzing cost per pound lost, patches represent extremely poor value

But dont be surprised if your provider recommends switching later on

Tirzepatide (Mounjaro): Commence with 5 mg subcutaneously once weekly, with subsequent weekly titration up to 15 mg or 20 mg, depending on patient response and tolerability

These populations are disproportionately affected by diabetes, yet face barriers to care as a result of high costs and shortages of Ozempic due to its popularity as a weight-loss drug

[1] The molecular signaling that links receptor engagement to sustained IGF-1 elevation is explored in our reference on how signaling networks drive tesamorelin-induced IGF-1 elevation